China Veterinary Active Pharmaceutical Ingredients Manufacturing Market Size & Outlook

The veterinary active pharmaceutical ingredients manufacturing market in China is expected to reach a projected revenue of US$ 937.1 million by 2030. A compound annual growth rate of 6.4% is expected of China veterinary active pharmaceutical ingredients manufacturing market from 2024 to 2030.
Revenue, 2023 (US$M)
$606.9
Forecast, 2030 (US$M)
$937.1
CAGR, 2024 - 2030
6.4%
Report Coverage
China

China veterinary active pharmaceutical ingredients manufacturing market, 2018-2030 (US$M)

China

Related Markets

China veterinary active pharmaceutical ingredients manufacturing market highlights

  • The China veterinary active pharmaceutical ingredients manufacturing market generated a revenue of USD 606.9 million in 2023 and is expected to reach USD 937.1 million by 2030.
  • The China market is expected to grow at a CAGR of 6.4% from 2024 to 2030.
  • In terms of segment, in house was the largest revenue generating service type in 2023.
  • Contract Outsourcing is the most lucrative service type segment registering the fastest growth during the forecast period.


Veterinary active pharmaceutical ingredients manufacturing market data book summary

Market revenue in 2023USD 606.9 million
Market revenue in 2030USD 937.1 million
Growth rate6.4% (CAGR from 2023 to 2030)
Largest segmentIn house
Fastest growing segmentContract Outsourcing
Historical data2018 - 2022
Base year2023
Forecast period2024 - 2030
Quantitative unitsRevenue in USD million
Market segmentationIn House, Contract Outsourcing
Key market players worldwideZoetis Inc Class A, SeQuent Scientific, Ofichem Group, The Chem-Pro Group, Siflon Drugs & Pharmaceuticals, Vetpharma, Suanfarma Biotech, Menadiona, Excel Industries


Other key industry trends

  • In terms of revenue, China accounted for 7.0% of the global veterinary active pharmaceutical ingredients manufacturing market in 2023.
  • Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
  • In Asia Pacific, China veterinary active pharmaceutical ingredients manufacturing market is projected to lead the regional market in terms of revenue in 2030.
  • India is the fastest growing regional market in Asia Pacific and is projected to reach USD 905.2 million by 2030.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Veterinary Active Pharmaceutical Ingredients Manufacturing Market Companies

Name Profile # Employees HQ Website

China veterinary active pharmaceutical ingredients manufacturing market outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to veterinary active pharmaceutical ingredients manufacturing market will help companies and investors design strategic landscapes.


In house was the largest segment with a revenue share of 61.89% in 2023. Horizon Databook has segmented the China veterinary active pharmaceutical ingredients manufacturing market based on in house, contract outsourcing covering the revenue growth of each sub-segment from 2018 to 2030.


The veterinary API manufacturing market in China is anticipated to witness significant growth over the forecast period. The prevalence of major outbreaks of animal diseases is expected to fuel the demand in the China veterinary API manufacturing market.

For instance, during the African Swine Fever outbreak, the livestock market, particularly the swine industry, faced substantial failures, resulting in significant deaths of pigs between 2 and 10 days after infection. This increased the need for effective treatments.

Since China’s food business majorly depends on animal products, extensive R&D is required to maintain the quality of feeds, pharmaceuticals, and vaccines. Hence, these aforementioned factors are anticipated to drive the market over the forecast period.

Reasons to subscribe to China veterinary active pharmaceutical ingredients manufacturing market databook:

  • Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
  • Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
  • Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
  • Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
  • Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of China veterinary active pharmaceutical ingredients manufacturing market databook

  • Our clientele includes a mix of veterinary active pharmaceutical ingredients manufacturing market companies, investment firms, advisory firms & academic institutions.
  • 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
  • Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
  • The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of country-level data and insights on the China veterinary active pharmaceutical ingredients manufacturing market , including forecasts for subscribers. This country databook contains high-level insights into China veterinary active pharmaceutical ingredients manufacturing market from 2018 to 2030, including revenue numbers, major trends, and company profiles.

Partial client list

  • logo

China veterinary active pharmaceutical ingredients manufacturing market size, by service type, 2018-2030 (US$M)

China Veterinary Active Pharmaceutical Ingredients Manufacturing Market Outlook Share, 2023 & 2030 (US$M)

China veterinary active pharmaceutical ingredients manufacturing market size, by service type, 2018-2030 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more